Shenglan Wang

Introduction: Shenglan Wang is a notable inventor based in Shanghai, China, known for his contributions to the field of pharmaceutical sciences. With 2 patents to his name, his work focuses on the development of novel compounds that hold significant promise for medical applications.

Latest Patents: His most recent patents include "Heteroaryl[4,3-C]pyrimidine-5-amine derivative, preparation method therefor, and medical uses thereof" and "Bicyclo-substituted pyrazolon azo derivatives, preparation process and pharmaceutical use thereof." The first patent details a heteroaryl[4,3-c]pyrimidin-5-amine derivative designed for therapeutic uses, particularly as A-receptor antagonists. The innovative compounds developed can be crucial in treating conditions that require A-receptor inhibition. The second patent focuses on bicyclo-substituted pyrazolon-azo derivatives, which can act as thrombopoietin mimetics and serve as agonists for thrombopoietin receptors, indicating their therapeutic potential in various medical scenarios.

Career Highlights: Shenglan Wang has made significant contributions while working at Jiangsu Hengrui Medicine Company Ltd. and Shanghai Hengrui Pharmaceutical Co., Ltd. His expertise in pharmaceuticals and patent development has greatly influenced advancements in therapeutic agents.

Collaborations: Throughout his career, Wang has collaborated with notable figures in his field, including Peng Cho Tang and Hejun Lü. These partnerships have facilitated the exchange of ideas and further innovation in pharmaceutical research.

Conclusion: Shenglan Wang's innovative work and patented inventions exemplify the vital role of inventors in advancing medical science. His contributions pave the way for new treatments that may improve patient outcomes, showcasing the continuous need for innovation in pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.